Embedded Files
Lexi Ventures is a top-20 investor in gene tech startups.
This focus is rooted in these beliefs.
We are at an inflection point in human innovation where biology is changing from science to engineering
This will change the lives of all people to a degree comparable with the industrial and info-tech revolutions.
Generational companies are being created now.
There will be more alpha in gene tech than other early stage VC.
Gene tech startups aim to cure many of the worst and most expensive diseases, improving happiness and reducing healthcare needs. Other gene tech startups will enable plants and microbes to produce newer and better things while sustaining the natural environment.
Lexi Ventures is one of the only investors concentrated exclusively in gene tech with diversification across industries.
For Startups
Lexi Ventures provides seed and pre-seed stage funding for US-based startups applying or enabling gene tech or synthetic biology.
Our key words are DNA, RNA, cell, omics.
Please connect if you are working on any of these.
A novel type of cell or gene therapy
Diagnostics using DNA, RNA, or proteins
Genetically engineered plants or microbes
Related software, chemistry, or devices
Lexi Ventures tends not to invest in
Small molecules
Single therapeutic assets
Medical devices
Consumer-facing software
Jonah Probell
Founder and Managing Partner
Jonah held founder, executive, and engineering roles in 7 startups. He achieved 2 IPOs, 16 granted patents and wrote 2 books. He has a lifelong interest in science, engineering, economics, philosophy, and innovation.
Jonah is known for:
experience inside many startups and roles
uncommon transparency and complete honesty
meticulous attention to details and finishing the job
concern with alignment of interests and prioritizing others' success
a patient approach to investing
Report abuse